SPY422.60-0.51 -0.12%
DIA338.78-0.67 -0.20%
IXIC14,271.73+18.47 0.13%

Significant Insider Sales in Shares of Illumina (ILMN) Extends the Selling Trend of Last Quarter

05/07/2021 18:28

10:20 PM EDT, 05/07/2021 (MT Newswires) -- Two insiders -- Jay T Flatley, Director, and Susan H Tousi, Officer -- today, sold 4,300 shares of Illumina having a market value of approximately $1,651,164, as reported in form 4 documents filed with the SEC. There have been 3 insiders with buy/sell transactions in the past 90 days prior to these filings. All of these trades have been sales resulting in the sale of 23,528 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 27,828 shares and have averaged 5,566 shares per transaction over this time period.

Today's Insider Activity

Over the last 90 days, the number of insider buy/sell trades at Illumina is greater than its 100-company peer group average. The Advanced Medical Equipment & Technology peer group saw 104 buy/sell trades during this period for an average of 1.0 transactions per company. However, the number of shares traded per transaction by Illumina insiders is lower than its peers. Within the peer group there were 277,626 shares purchased and 1,227,681 shares sold with company insiders disposing of 9,135 shares on average over this time period.

The data obtained in evaluating and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.

[Disclaimer]
This report does not constitute a recommendation to purchase or sell any security and the analysts are not registered investment advisors. Further analysis is recommended before undertaking any position in any security. Any risks are solely the responsibility of the buyer/seller. The authors, publishers and distributors of the MT Newswires Live Briefs service and any associates thereof accept no liability for the content or actions taken by anyone or institution utilizing this report.